Better Therapeutics Inc (BTTX) Financials

$0.00

$-0.01 (-99.15%)

As on 29-Jan-2025 15:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	0.01	0.02	--
Cost of Revenue	3.11	2.73	1.62	0.68	0.90	--
Gross Profit	-3.11	-2.73	-1.62	-0.67	-0.88	--
Operating Expenses	29.61	38.26	30.56	5.65	4.89	--
Operating Profit (EBIT)	-29.61	-38.26	-30.56	-6.32	-5.77	--
Other Income	--	--	--	--	--	--
Profit before Tax	-31.56	-39.75	-40.49	-6.23	-5.78	--
Provision for Tax	0.01	0.01	-0.15	0.15	0.01	--
Profit after Tax (Net Income)	-31.57	-39.76	-40.34	-6.39	-5.80	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-23.94	-39.76	-40.34	-10.31	-8.23	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-9.94	-0.90	36.72	-6.76	-0.61	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.72	10.35	9.51	12.53	5.00	--
Current Liabilities	12.94	13.49	4.73	0.61	0.49	--
Total Liabilities	23.66	22.94	50.96	6.39	4.88	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	3.38	4.50	5.71	5.92	3.89	--
Current Assets	7.35	18.45	45.25	0.46	0.99	--
Total Assets	23.66	22.94	50.96	6.39	4.88	--
Total Debt*	14.31	14.88	9.51	0.64	5.00	--
Net Current Assets	-5.59	4.95	40.52	-0.15	0.50	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-28.93	-30.82	-5.77	-6.22	--
Cash Flow from Investing Activities	--	-1.18	-1.07	-2.31	-2.74	--
Cash from Financing Activities	--	5.28	0.07	7.45	8.70	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.16	-1.67	-2.05	--	--	--
Cash EPS ($)	--	-1.56	-1.97	--	--	--
Adjusted Book Value ($)	--	--	1.87	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.22	-1.57	--	--	--
Free Cash Flow per Share ($)	--	-1.27	-1.62	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-132.08	-201.14	741.38	--	--
ROE (%)	--	-221.99	-269.24	173.49	--	--
ROA (%)	-103.19	-107.60	-140.67	-113.37	--	--
EBIT Margin (%)	--	--	--	-79,037.50	-32,072.22	--
Net Margin (%)	--	--	--	-79,837.50	-32,194.44	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	-1.00	-0.56	--	--
EBIT Growth (%)	24.06	-25.20	-383.31	-9.53	--	--
Net Profit Growth (%)	30.16	1.43	-531.52	-10.22	--	--
EPS Growth (%)	43.11	0.18	--	--	--	--
Book Value Growth (%)	-184.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.66	-2.27	--	--	--
Price / Book Value	2.29	-29.19	2.49	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.46	-0.71	-2.09	--	--	--
Close Price ($)	0.37	1.11	4.65	--	--	--
High Price ($)	1.86	5.14	29.40	--	--	--
Low Price ($)	0.32	0.91	4.41	--	--	--
Market Cap ($ Cr)	0.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	-0.78	-16.55	0.26	-0.09	-8.26	--
Short term debt to equity ratio	-0.66	-5.04	--	--	--	--
Current Ratio	0.57	1.37	9.56	0.76	2.03	--
Quick Ratio	0.57	--	--	--	--	--
Interest Coverage	-15.18	-25.66	-165.19	-63.23	-524.82	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	2,700.00	--	--
Asset Turnover	--	--	--	0.00	--	--
Receivable days	--	--	--	9,861.75	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	305.02	229.78	227.34	136.26	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.